Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2000 5
2001 6
2002 5
2003 5
2004 1
2005 1
2006 5
2007 4
2008 5
2009 4
2010 4
2011 2
2012 6
2013 8
2014 19
2015 10
2016 10
2017 9
2018 8
2019 7
2020 4
2021 5
2022 1
2023 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O; International Breast Cancer Study Group; POSITIVE Trial Collaborators. Partridge AH, et al. N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856. N Engl J Med. 2023. PMID: 37133584 Free PMC article. Clinical Trial.
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.
Iwase T, Saji S, Iijima K, Higaki K, Ohtani S, Sato Y, Hozumi Y, Hasegawa Y, Yanagita Y, Takei H, Tanaka M, Masuoka H, Tanabe M, Egawa C, Komoike Y, Nakamura T, Ohtsu H, Mukai H. Iwase T, et al. Among authors: egawa c. J Clin Oncol. 2023 Jun 20;41(18):3329-3338. doi: 10.1200/JCO.22.00577. Epub 2023 Apr 20. J Clin Oncol. 2023. PMID: 37079878 Clinical Trial.
Curbing the major and growing threats from invasive alien species is urgent and achievable.
Roy HE, Pauchard A, Stoett PJ, Renard Truong T, Meyerson LA, Bacher S, Galil BS, Hulme PE, Ikeda T, Kavileveettil S, McGeoch MA, Nuñez MA, Ordonez A, Rahlao SJ, Schwindt E, Seebens H, Sheppard AW, Vandvik V, Aleksanyan A, Ansong M, August T, Blanchard R, Brugnoli E, Bukombe JK, Bwalya B, Byun C, Camacho-Cervantes M, Cassey P, Castillo ML, Courchamp F, Dehnen-Schmutz K, Zenni RD, Egawa C, Essl F, Fayvush G, Fernandez RD, Fernandez M, Foxcroft LC, Genovesi P, Groom QJ, González AI, Helm A, Herrera I, Hiremath AJ, Howard PL, Hui C, Ikegami M, Keskin E, Koyama A, Ksenofontov S, Lenzner B, Lipinskaya T, Lockwood JL, Mangwa DC, Martinou AF, McDermott SM, Morales CL, Müllerová J, Mungi NA, Munishi LK, Ojaveer H, Pagad SN, Pallewatta NPKTS, Peacock LR, Per E, Pergl J, Preda C, Pyšek P, Rai RK, Ricciardi A, Richardson DM, Riley S, Rono BJ, Ryan-Colton E, Saeedi H, Shrestha BB, Simberloff D, Tawake A, Tricarico E, Vanderhoeven S, Vicente J, Vilà M, Wanzala W, Werenkraut V, Weyl OLF, Wilson JRU, Xavier RO, Ziller SR. Roy HE, et al. Among authors: egawa c. Nat Ecol Evol. 2024 Jul;8(7):1216-1223. doi: 10.1038/s41559-024-02412-w. Epub 2024 Jun 3. Nat Ecol Evol. 2024. PMID: 38831016 Review.
Predictive factors for anthracycline-based chemotherapy for human breast cancer.
Miyoshi Y, Kurosumi M, Kurebayashi J, Matsuura N, Takahashi M, Tokunaga E, Egawa C, Masuda N, Kono S, Morimoto K, Kim SJ, Okishiro M, Yanagisawa T, Ueda S, Taguchi T, Tamaki Y, Noguchi S. Miyoshi Y, et al. Among authors: egawa c. Breast Cancer. 2010 Apr;17(2):103-9. doi: 10.1007/s12282-009-0152-6. Epub 2009 Aug 6. Breast Cancer. 2010. PMID: 19657712 Review.
[Occult Breast Cancer Presenting with a Swelling Axillary Lymph Node-A Case Report].
Kikumori K, Oshima K, Yanagawa T, Egawa C, Takatsuka Y, Shinke G, Katsuyama S, Kawai K, Hiraki M, Katsura Y, Ohmura Y, Masuzawa T, Hata T, Takeda Y, Murata K. Kikumori K, et al. Among authors: egawa c. Gan To Kagaku Ryoho. 2021 Dec;48(13):1849-1851. Gan To Kagaku Ryoho. 2021. PMID: 35045425 Review. Japanese.
[A Case of Granulocyte-Colony Stimulating Factor-Producing Gastric Cancer Successfully Treated with Trastuzumab].
Matsushita K, Takeno A, Tamura S, Taniguchi H, Ishida T, Sato Y, Morimoto Y, Kusama H, Hashimoto T, Kimura K, Katsura Y, Ohmura Y, Nitta K, Kagawa Y, Okisiro M, Sakisaka H, Egawa C, Takeda Y, Kato T. Matsushita K, et al. Among authors: egawa c. Gan To Kagaku Ryoho. 2015 Nov;42(12):1968-70. Gan To Kagaku Ryoho. 2015. PMID: 26805233 Review. Japanese.
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.
Miyagawa Y, Yanai A, Yanagawa T, Inatome J, Egawa C, Nishimukai A, Takamoto K, Morimoto T, Kikawa Y, Suwa H, Taji T, Yamaguchi A, Okada Y, Sata A, Fukui R, Bun A, Ozawa H, Higuchi T, Fujimoto Y, Imamura M, Miyoshi Y. Miyagawa Y, et al. Among authors: egawa c. Oncotarget. 2020 Jan 7;11(1):86-98. doi: 10.18632/oncotarget.27423. eCollection 2020 Jan 7. Oncotarget. 2020. PMID: 32002126 Free PMC article.
131 results